Progression of diabetic retinopathy in patients treated with 0.2 μg/day

Related

• 

  Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent

  Nancy M. Holekamp, MD, FASRS

  J. Michael Jumper, MD, FASRS

  Paul Chan

  Adrienne W. Scott, MD, FASRS

  Webinars and Journal Clubs

  2017

• 

  Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017

• 

  Expert Panel: Socioeconomics

  Linda A. Lam, MD, MBA, FASRS

  Ella H Leung, MD

  Mohsin H. Ali, MD

  Hasenin Al-khersan, MD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2024